HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raj K Puri Selected Research

Messenger RNA (mRNA)

1/2019Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.
12/2018Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway.
2/2018Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
12/2014Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease.
11/2008Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.
3/2005Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells.
9/2004Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
8/2003Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.
3/2003Interleukin-4 receptor-targeted cytotoxin therapy of androgen-dependent and -independent prostate carcinoma in xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raj K Puri Research Topics

Disease

92Neoplasms (Cancer)
05/2024 - 01/2002
27Glioma (Gliomas)
01/2023 - 10/2002
17Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2002
11Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 07/2002
11Brain Neoplasms (Brain Tumor)
03/2009 - 01/2002
10Squamous Cell Carcinoma of Head and Neck
03/2014 - 01/2002
7Breast Neoplasms (Breast Cancer)
01/2022 - 05/2003
7Neoplasm Metastasis (Metastasis)
01/2021 - 09/2005
6Head and Neck Neoplasms (Head and Neck Cancer)
02/2013 - 02/2002
5Fibrosis (Cirrhosis)
11/2013 - 01/2006
4Infections
03/2023 - 08/2005
4Adenocarcinoma
05/2020 - 10/2007
4Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 09/2005
4Carcinoma (Carcinomatosis)
12/2014 - 03/2003
4Melanoma (Melanoma, Malignant)
07/2012 - 04/2006
4Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2010 - 05/2003
3Adrenocortical Carcinoma
01/2022 - 07/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 11/2002
3Lung Neoplasms (Lung Cancer)
01/2019 - 11/2002
3Inflammation (Inflammations)
01/2017 - 06/2008
3Prostatic Neoplasms (Prostate Cancer)
03/2015 - 03/2003
3Granuloma
11/2013 - 10/2002
3Necrosis
08/2009 - 08/2003
3Kaposi Sarcoma (Kaposi's Sarcoma)
01/2006 - 01/2002
3Asthma (Bronchial Asthma)
01/2006 - 06/2002
3Idiopathic Pulmonary Fibrosis
06/2004 - 09/2003
3Idiopathic Interstitial Pneumonias
06/2004 - 09/2003
2Astrocytoma (Pilocytic Astrocytoma)
12/2018 - 10/2003
2Urinary Bladder Neoplasms (Bladder Cancer)
03/2015 - 12/2014
2Lymphatic Metastasis
07/2012 - 05/2005
2Carcinogenesis
01/2012 - 06/2007
2Sarcoma (Soft Tissue Sarcoma)
11/2011 - 11/2010
2Hodgkin Disease (Hodgkin's Disease)
11/2006 - 05/2005
2Acquired Immunodeficiency Syndrome (AIDS)
01/2006 - 08/2004
2Hypersensitivity (Allergy)
01/2006 - 05/2004
2Renal Cell Carcinoma (Grawitz Tumor)
08/2004 - 01/2002
1Body Weight (Weight, Body)
05/2024
1Vaccinia
03/2023
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Adrenal Cortex Neoplasms (Adrenocortical Cancer)
06/2021
1Testicular Neoplasms (Testicular Cancer)
06/2021

Drug/Important Bio-Agent (IBA)

58Interleukin-13IBA
01/2022 - 02/2002
49Cytotoxins (Cytolysins)IBA
11/2011 - 01/2002
38ExotoxinsIBA
01/2019 - 02/2002
33Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
03/2023 - 02/2002
27Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2002
24Interleukin-4 (Interleukin 4)IBA
01/2019 - 01/2002
16Immunotoxins (Immunotoxin)IBA
09/2015 - 05/2003
14Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
11/2015 - 01/2002
14IL13-PE38IBA
08/2010 - 02/2002
13CytokinesIBA
01/2022 - 06/2002
11Biomarkers (Surrogate Marker)IBA
06/2021 - 10/2002
11Interleukin-13 Receptor alpha2 SubunitIBA
05/2020 - 10/2002
10AntigensIBA
03/2023 - 08/2003
10InterleukinsIBA
11/2006 - 06/2002
9Messenger RNA (mRNA)IBA
01/2019 - 03/2003
7InterferonsIBA
01/2023 - 08/2002
6Pseudomonas aeruginosa Exotoxin AIBA
01/2010 - 10/2003
5LigandsIBA
06/2021 - 02/2003
5Peptides (Polypeptides)IBA
06/2021 - 02/2003
5Cell Surface ReceptorsIBA
04/2012 - 10/2003
5interleukin-4-Pseudomonas exotoxinIBA
07/2005 - 07/2002
4EnzymesIBA
05/2024 - 10/2008
4VaccinesIBA
03/2023 - 09/2008
4Cytokine Receptors (Cytokine Receptor)IBA
09/2015 - 08/2002
4Complementary DNA (cDNA)IBA
01/2015 - 10/2003
4Cancer VaccinesIBA
01/2014 - 07/2009
4Neoplasm Antigens (Tumor Antigens)IBA
02/2013 - 11/2008
4Recombinant Fusion ProteinsIBA
08/2004 - 05/2003
3Chimeric Antigen ReceptorsIBA
05/2024 - 01/2023
3Carrier Proteins (Binding Protein)IBA
06/2021 - 08/2002
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2018 - 11/2009
3CollagenIBA
03/2014 - 10/2002
3Matrix Metalloproteinases (MMPs)IBA
07/2012 - 11/2009
3DNA VaccinesIBA
11/2011 - 04/2006
3DNA (Deoxyribonucleic Acid)IBA
11/2011 - 02/2002
3Interleukin-13 Receptor alpha1 SubunitIBA
01/2006 - 12/2003
3Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2004 - 10/2002
2Hormones (Hormone)IBA
01/2021 - 11/2008
2Transcription Factors (Transcription Factor)IBA
12/2018 - 05/2008
2GemcitabineFDA Link
03/2011 - 10/2007
2poliferprosan 20 drug combination carmustine (Gliadel)FDA Link
08/2010 - 04/2006
2Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2010 - 01/2006
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2010 - 09/2003
2AdrenomedullinIBA
11/2008 - 05/2005
2RNA (Ribonucleic Acid)IBA
06/2008 - 06/2005
2Human Serum AlbuminFDA LinkGeneric
03/2007 - 02/2007
2Therapeutic UsesIBA
08/2004 - 09/2003
2SteroidsIBA
01/2004 - 09/2003
2Caspase 3 (Caspase-3)IBA
01/2003 - 10/2002
1Codon (Codons)IBA
05/2024
1AntibodiesIBA
03/2023
1A-Form DNA (A-DNA)IBA
03/2023

Therapy/Procedure

56Therapeutics
01/2022 - 01/2002
13Immunotherapy
03/2023 - 02/2002
6Catheters
08/2010 - 02/2005
3Injections
12/2004 - 07/2002
2Intranasal Administration
01/2010 - 09/2003
2Radiotherapy
11/2007 - 10/2003
2Aftercare (After-Treatment)
10/2002 - 02/2002